Distinct Pathological Pathways in Patients With Heart Failure and Diabetes

Authors:

Abstract
No abstract available
Funding Information
  • Sanofi
  • Medtronic
  • Amgen
  • Boehringer Ingelheim
  • Pfizer
  • Merck Sharp and Dohme United Kingdom
  • Roche
  • GlaxoSmithKline
  • European Commission (EudraCT 2010-020808-29, FP7-242209-BIOSTAT-CHF)
  • Johnson and Johnson
  • Biotronik
  • Merck
  • Servier
  • Novartis
  • Abbott Vascular
  • Bayer
  • Cytokinetics
  • AstraZeneca